TABLE 1.
Patient characteristics.
| Characteristics | Sarcoidosis (127) | Healthy (82) | P-value |
| Age (mean, SD) | 55.1, 11.9 | 57.0, 16.7 | 0.37 |
| Female | 65.4 | 40.2 | <0.01 |
| Race (W, AA, NA) | 48.8, 31.5, 0 | 82, 9, 1.2 | <0.01 |
| Ethnicity (Hispanic) | 11.0 | 15.8 | 0.31 |
| Complicated* | 48.8 | NA | NA |
| Scadding stage | NA | NA | |
| 0 | 5.5 | ||
| I | 6.3 | ||
| II | 15.0 | ||
| III | 14.2 | ||
| IV ** | 15.0 | ||
| Organ involvement | NA | NA | |
| Neurological | 9.4 | ||
| Eye | 58.8 | ||
| Cardiac | 8.7 | ||
| Other (Bone, liver, skin) | 15.7 |
Age was reported in mean ± standard deviation (sd). Numbers in the rest of the variables are reported as percentages. Race, W, White non-Hispanic; AA, African American; NA, Native American.
*Complicated status was defined according to the following parameters: Lung involvement: Documented parenchymal lung disease by CT scan or radiographic stages III and IV and/or PFT with FVC <50%. Organ involvement: Cardiac or neurological involvement.
**Stage IV pulmonary fibrosis: according to the chest radiographic or CT scan classification (hilar retraction, bullae, cysts, ground-glass opacities, honeycombing, and emphysema).